Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Mark T Butt"'
Autor:
Orion P Keifer, Juanmarco Gutierrez, Mark T Butt, Sarah D Cramer, Raymond Bartus, Malu Tansey, Daniel Deaver, Alexandre Betourne, Nicholas M Boulis
Publikováno v:
PLoS ONE, Vol 18, Iss 8, p e0277718 (2023)
Riluzole is the only treatment known to improve survival in patients with Amyotrophic Lateral Sclerosis (ALS). However, oral riluzole efficacy is modest at best, further it is known to have large inter-individual variability of serum concentration an
Externí odkaz:
https://doaj.org/article/7df620d86c554759a272218b0a7868ed
Autor:
Richard Jay Smeyne, Charles B Breckenridge, Melissa Beck, Yun Jiao, Mark T Butt, Jeffrey C Wolf, Dan Zadory, Daniel J Minnema, Nicholas C Sturgess, Kim Z Travis, Andrew R Cook, Lewis L Smith, Philip A Botham
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0164094 (2016)
The neurotoxicity of paraquat dichloride (PQ) was assessed in two inbred strains of 9- or 16-week old male C57BL/6 mice housed in two different laboratories and compared to the effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). PQ was ad
Externí odkaz:
https://doaj.org/article/f994ce1641f14c128b4b02f13f570ad2
Autor:
Jason Pinkstaff, Emma McCullagh, Anita Grover, Andrew C. Melton, Anu Cherukuri, Jill CM Wait, Annalisa Nguyen, Mark T. Butt, Jami L. Trombley, Randall P. Reed, Eric.L. Adams, Robert B. Boyd, Sundeep Chandra, Joshua Henshaw, Charles A. O’Neill, Eric Zanelli, Joseph Kovalchin
Publikováno v:
Toxicology Reports. 10:357-366
Autor:
Orion P. Keifer, Juan Marco Gutierrez, Mark T. Butt, Sarah D. Cramer, Raymond Bartus, Malu Tansey, Daniel Deaver, Alexandre Betourne, Nicholas M Boulis
SummaryRiluzole is the only treatment known to improve survival in patients with Amyotrophic Lateral Sclerosis (ALS). However, oral riluzole efficacy is modest at best, further it is known to have large inter-individual variability of serum concentra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::20d02187bf64e97949c9572636589104
https://doi.org/10.1101/2022.11.02.514962
https://doi.org/10.1101/2022.11.02.514962
Publikováno v:
Toxicology Letters. 344:34-45
ASP7962 is a small molecule inhibitor for the nerve growth factor (NGF) receptor, tropomyosin-related kinase A (TrkA). NGF contributes to the survival of sensory and sympathetic neurons through TrkA receptor activation. Gross, microscopic, and quanti
Autor:
Brad Bolon, Kevin D. Woolard, Lisa G. Lanigan, Bernard S Jortner, Duncan S. Russell, Virginia Godfrey, Ingrid D. Pardo, Mark T. Butt
Publikováno v:
Veterinary Pathology. 58:10-33
The peripheral nervous system (PNS) relays messages between the central nervous system (brain and spinal cord) and the body. Despite this critical role and widespread distribution, the PNS is often overlooked when investigating disease in diagnostic
Autor:
Alys Bradley, Ramesh C. Kovi, Wolfgang Kaufmann, Deepa B. Rao, Mark T. Butt, Alok K. Sharma, Sibylle Gröters, Robert C. Sills, Robert H. Garman, Brad Bolon, Peter B Little, Sarah D Cramer, Makoto Shibutani, Catherine George, Stephanie Czasch, Georg Krinke, Isao Narama
Publikováno v:
Toxicologic Pathology. 48:827-844
Harmonization of diagnostic terminology used during the histopathologic analysis of rodent tissue sections from nonclinical toxicity studies will improve the consistency of data sets produced by laboratories located around the world. The INHAND Proje
Publikováno v:
Toxicologic Pathology. 48:238-243
Although necrosis and apoptosis are uncommon, autophagy of sensory neurons (ASN) in trigeminal and dorsal root ganglia is a very common, spontaneous finding in cynomolgus monkeys ( Macaca fascicularis). Data from one author’s (Butt) laboratory show
Autor:
Georg Krinke, Brad Bolon, Bernard S Jortner, Deepa B. Rao, Karl F. Jensen, Robert H. Garman, Mark T. Butt, Lydia L. Andrews-Jones, Michael S. Thibodeau, Ingrid D. Pardo, James P. Morrison, Alok K. Sharma
Publikováno v:
Toxicologic Pathology. 46:372-402
Peripheral nervous system (PNS) toxicity is surveyed inconsistently in nonclinical general toxicity studies. These Society of Toxicologic Pathology “best practice” recommendations are designed to ensure consistent, efficient, and effective sampli
Autor:
Patrice Belanger, Mark T. Butt, Thomas Cummings, Mark G. Evans, Mark Zorbas, Jessica-lyn Gremminger
Publikováno v:
Autonomic Neuroscience. 218:51-53
Tanezumab, a humanized monoclonal anti-NGF antibody, has demonstrated efficacy and safety profiles in Phase III clinical trials of chronic pain. In a 24-week study in non-human primates, morphological observations of sympathetic ganglia showed decrea